These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34145747)

  • 1. A Tumor-Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer.
    Tong QS; Miao WM; Huang H; Luo JQ; Liu R; Huang YC; Zhao DK; Shen S; Du JZ; Wang J
    Small; 2021 Jul; 17(29):e2101208. PubMed ID: 34145747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic virus-mediated reducing of myeloid-derived suppressor cells enhances the efficacy of PD-L1 blockade in gemcitabine-resistant pancreatic cancer.
    Kajiwara Y; Tazawa H; Yamada M; Kanaya N; Fushimi T; Kikuchi S; Kuroda S; Ohara T; Noma K; Yoshida R; Umeda Y; Urata Y; Kagawa S; Fujiwara T
    Cancer Immunol Immunother; 2023 May; 72(5):1285-1300. PubMed ID: 36436021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer.
    Wang R; Hong K; Zhang Q; Cao J; Huang T; Xiao Z; Wang Y; Shuai X
    Acta Biomater; 2023 Oct; 169():451-463. PubMed ID: 37572982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy.
    Qu C; Yuan H; Tian M; Zhang X; Xia P; Shi G; Hou R; Li J; Jiang H; Yang Z; Chen T; Li Z; Wang J; Yuan Y
    ACS Nano; 2024 Feb; 18(5):4019-4037. PubMed ID: 38253029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
    Fan JQ; Wang MF; Chen HL; Shang D; Das JK; Song J
    Mol Cancer; 2020 Feb; 19(1):32. PubMed ID: 32061257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency.
    Chen D; Zhu X; Tao W; Kong Y; Huag Y; Zhang Y; Liu R; Jiang L; Tang Y; Yu H; Hao Q; Yang X; Zou H; Chen J; Lu Y; Zhang H; Li W
    J Control Release; 2020 Aug; 324():545-559. PubMed ID: 32504777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
    Urbanova M; Cihova M; Buocikova V; Slopovsky J; Dubovan P; Pindak D; Tomas M; García-Bermejo L; Rodríguez-Garrote M; Earl J; Kohl Y; Kataki A; Dusinska M; Sainz B; Smolkova B; Gabelova A
    Biomed Pharmacother; 2023 Sep; 165():115179. PubMed ID: 37481927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma.
    Wang M; Hu Q; Huang J; Zhang F; Yao Z; Shao S; Zhao X; Liang T
    Adv Healthc Mater; 2023 Aug; 12(20):e2203264. PubMed ID: 36971070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic Tumor Microenvironment.
    Wang K; He H
    Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailored Chemodynamic Nanomedicine Improves Pancreatic Cancer Treatment via Controllable Damaging Neoplastic Cells and Reprogramming Tumor Microenvironment.
    Chen Y; Huang Y; Zhou S; Sun M; Chen L; Wang J; Xu M; Liu S; Liang K; Zhang Q; Jiang T; Song Q; Jiang G; Tang X; Gao X; Chen J
    Nano Lett; 2020 Sep; 20(9):6780-6790. PubMed ID: 32809834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy.
    Yu N; Zhang X; Zhong H; Mu J; Li X; Liu T; Shi X; Liang XJ; Guo S
    Nano Lett; 2022 Nov; 22(21):8744-8754. PubMed ID: 36279310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-inhibition of the TGF-β pathway and the PD-L1 checkpoint by pH-responsive clustered nanoparticles for pancreatic cancer microenvironment regulation and anti-tumor immunotherapy.
    Wang Y; Gao Z; Du X; Chen S; Zhang W; Wang J; Li H; He X; Cao J; Wang J
    Biomater Sci; 2020 Sep; 8(18):5121-5132. PubMed ID: 32820750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.
    Wang M; Hu Q; Huang J; Zhao X; Shao S; Zhang F; Yao Z; Ping Y; Liang T
    J Nanobiotechnology; 2022 Feb; 20(1):85. PubMed ID: 35177078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gradient tumor microenvironment-promoted penetrating micelles for hypoxia relief and immunosuppression reversion in pancreatic cancer treatment.
    Luo Y; Li C; Zhang Y; Liu P; Chen H; Zhao Z; Wang Y; Zhou Z; Song H; Su B; Li C; Li X; Zhang T; You H; Wu Y; Tian Z; Zhang S; Guo Y; Fan H; Chen Q; Jiang C; Sun T
    Acta Biomater; 2023 Sep; 167():387-400. PubMed ID: 37276955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetrating Micelle for Reversing Immunosuppression and Drug Resistance in Pancreatic Cancer Treatment.
    Chen Q; Wang Q; Wang Y; Chu Y; Luo Y; You H; Su B; Li C; Guo Q; Sun T; Jiang C
    Small; 2022 May; 18(18):e2107712. PubMed ID: 35285149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer.
    Lu T; Prakash J
    Int J Nanomedicine; 2021; 16():6313-6328. PubMed ID: 34552327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide-induced stromal depletion for improved nanoparticle penetration in pancreatic cancer treatment.
    Chen X; Jia F; Li Y; Deng Y; Huang Y; Liu W; Jin Q; Ji J
    Biomaterials; 2020 Jul; 246():119999. PubMed ID: 32247201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy.
    Hou W; Yang B; Zhu H
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.